Orientation-aware Fragmentation (OCF)
Command: krewlyzer ocf
Purpose
Computes orientation-aware cfDNA fragmentation (OCF) values in tissue-specific open chromatin regions.
Biological Context
OCF (Sun et al., 2019) measures the phasing of upstream (U) and downstream (D) fragment ends in open chromatin, informing tissue-of-origin of cfDNA.
Usage
Output
{sample}.OCF.tsv: Summary of OCF calculations per tissue type.{sample}.OCF.sync.tsv: Detailed sync scores.
Options
--threads,-t: Number of processes
Calculation Details
- Alignment: Fragments are mapped relative to the center of the Open Chromatin Region (OCR).
- Counting:
Leftends (Start) andRightends (End) are counted in 10bp bins across a ±1000bp window.- Counts are normalized by total sequencing depth.
- OCF Score:
$$ OCF = \sum_{Peak} P_{signal} - \sum_{Peak} P_{background} $$
- Signal: Right ends at -60bp and Left ends at +60bp (Phased nucleosome boundaries).
- Background: Left ends at -60bp and Right ends at +60bp (Unphased).
Clinical Interpretation
Healthy Plasma Baseline
In healthy individuals, cfDNA primarily originates from:
| Tissue | OCF Value |
|---|---|
| T-cells (hematopoietic) | Highest |
| Liver | Second highest |
| Other tissues | Near zero |
Detecting Tumor-Derived cfDNA
When comparing a sample to healthy plasma:
| Pattern | Interpretation |
|---|---|
| ↑ Tissue-specific OCF | Tumor shedding from that tissue |
| ↓ T-cell OCF | Dilution of hematopoietic cfDNA by tumor DNA |
| OCF correlates with tumor fraction | Higher ctDNA → stronger tissue signal |
Cancer-Specific Patterns
| Cancer Type | Expected OCF Change |
|---|---|
| Hepatocellular carcinoma | ↑ Liver OCF |
| Colorectal cancer | ↑ Intestine OCF, ↓ T-cell OCF |
| Lung cancer | ↑ Lung OCF, ↓ T-cell OCF |
Reference: See Citation & Scientific Background for detailed paper summary.